Phase I small molecule clinical trial share
RecordSTO-01M2KJ7XCF-5037JCNPDK-KT7NP3
Global · 2023
Phase I small molecule clinical trial share worldwide was 60% in 2023 (IQVIA).
Phase I small molecule clinical trial share: every country and year, and how it is measured
- Publisher
- IQVIA
- Authority tier
- T3 Research
- Report
- Global R&D Trends 2026
- Locator
- Exhibit 21: Small molecule share of trial starts by phase and company segment, 2016–2025
- Retrieved
- 15 Sep 2026
- Status
- Verified
What the source says
Between 2016 and 2023, trials examining small molecule drugs in Phase I declined from 72% to 60% of trials before increasing to reach 62% in 2025.
Checked: the figure 60%is stated in this passage. If it does not match, the extraction is wrong and we want to know.
Cite this figure
APA
IQVIA Institute. (2023). Global R&D Trends 2026. Retrieved September 15, 2026, from https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/global-trends-in-r-and-d-2025. Via StatOrigin, https://statorigin.org/stat/stat_01M2KJ7XCF5037JCNPDKKT7NP3
Other formats: MLA, Chicago, BibTeX
- MLA
- IQVIA Institute. "Global R&D Trends 2026." 2023, https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/global-trends-in-r-and-d-2025. Accessed 15 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_01M2KJ7XCF5037JCNPDKKT7NP3.
- Chicago
- IQVIA Institute. "Global R&D Trends 2026." 2023. https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/global-trends-in-r-and-d-2025. Accessed September 15, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_01M2KJ7XCF5037JCNPDKKT7NP3.
- BibTeX
- @misc{iqvia2023phasekt7np3, author = {{IQVIA Institute}}, title = {Global R\&D Trends 2026}, year = {2023}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_01M2KJ7XCF5037JCNPDKKT7NP3}, note = {Original source: https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/global-trends-in-r-and-d-2025. Accessed September 15, 2026.} }
Data published under CC BY 4.0. The citation credits the original publisher and links to this permanent record.
Provenance and verification
Everything needed to check this number yourself, without taking our word for it.
Primary source
- Publisher
- IQVIA Institute · homepage ↗
- Authority tier
- Tier 3 · Research and companies
- Report
- Global R&D Trends 2026
- Type
- Press release
- Published
- —
- Locator
- Exhibit 21: Small molecule share of trial starts by phase and company segment, 2016–2025
- Retrieved
- 15 September 2026
- Link status
- Reachable (HTTP 200)
- Report licence
- See source
Verification
- Status
- Verified
- Review protocol
- Editorial review
- Checked on
- 15 September 2026
- Last revision
- 15 September 2026
- Permanent URL
- /stat/stat_01M2KJ7XCF5037JCNPDKKT7NP3